Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
33 /100
MEDIUM RISK
Score updated Aug 28, 2026

BPTH — Bio-Path Holdings, Inc. Dilution Risk Tracker

Track BPTH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BPTH — Get alerts when the score changes →

As of August 28, 2026, Bio-Path Holdings, Inc. (BPTH) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. Bio-Path Holdings, Inc. has a market capitalization of $1.51M, 50.30M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 44.6K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.05 below $1 exchange minimum
🔔 Track BPTH — Get forecast alerts →

Market Data

Market Cap$1.51M
Shares Outstanding50.30M
Float49.91M
CashN/A
Debt$511.0K
Short InterestN/A

Institutional Holdings

1 institutional holders · 4 shares
#1 DANSKE BANK A/S 4 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.4K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-09-30
xbrl XBRL WARRANT 2024-12-31
8-K 8K EVENT 2026-03-20
8-K 8K EVENT 2026-02-24
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BPTH Dilution Snapshot

Bio-Path Holdings, Inc. (BPTH) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BPTH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BPTH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BPTH
BPTH FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.